People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.34USD
12:44pm EDT
Price Change (% chg)

$0.05 (+3.88%)
Prev Close
$1.29
Open
$1.30
Day's High
$1.36
Day's Low
$1.30
Volume
11,613
Avg. Vol
53,497
52-wk High
$4.33
52-wk Low
$1.09

Search Stocks

Babiss, Lee 

Brief Biography

Dr. Lee E. Babiss, Ph.D., is Lead Independent Director of Athersys, Inc., since August 9, 2010. Dr. Babiss is currently Chief Scientific Officer and Executive Vice President of Discovery Innovation of PPD, Inc., a contract research organization, where he has served since February 2010, and Chief Executive Officer of X-Rx, a majority-owned subsidiary of PPD, Inc., providing strategic direction and scientific leadership in support of drug discovery. Dr. Babiss was formerly President and Director of Global Pharmaceutical Research at Roche, a pharmaceutical company, from 1998 until his appointment at PPD, Inc. Prior to Roche, Dr. Babiss spent seven years with Glaxo, Inc., now GlaxoSmithKline, a pharmaceutical company, where he held senior positions, including Vice President of Biological Sciences and Genetics. Dr. Babiss received his doctorate in Microbiology from Columbia University and completed his postdoctoral fellowship at the Rockefeller University, where he served as an assistant and associate professor. Dr. Babiss has received numerous fellowship awards and grants and serves on several scientific advisory committees and boards. Dr. Babiss has published over 60 peer-reviewed scientific papers.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gil Bokkelen

2,034,490

William Lehmann

1,605,450

John Harrington

1,575,900

Robert Deans

1,342,910

Laura Campbell

1,004,240

Lee Babiss

--
As Of 30 Dec 2013
Search Stocks